Evolution AB/ SE0012673267 /
10/07/2024 17:24:52 | Chg. +22.50 | Volume | Bid17:25:00 | Ask17:25:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,141.00SEK | +2.01% | 128,169 Turnover: 71.82 mill. |
-Bid Size: - | -Ask Size: - | 245.79 bill.SEK | - | - |
GlobeNewswire
24/06
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire
21/06
Revolutionizing Gaming: Secret Casino Tips Release New Article on The Cutting-Edge Technologies Behi...
GlobeNewswire
20/06
Welsbach Technology Metals Acquisition Corp. Announces Extension Proposal and Non-Redemption Agreeme...
GlobeNewswire
19/06
OSE Immunotherapeutics Reports on its 2024 General Shareholders’ Meeting and the Evolution of the B...
GlobeNewswire
18/06
Sterling Digital Print Adds Second Canon varioPRINT iX Sheetfed Inkjet Press Just Months After First...
GlobeNewswire
18/06
Atsign Announces Evolution of Secure Remote Access Solution: Introducing NoPorts
GlobeNewswire
18/06
4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire
13/06
Lantronix Wins 2024 IoT Evolution Asset Tracking Award for FOX3 Telematic Gateway
GlobeNewswire
08/06
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
GlobeNewswire
06/06
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...
GlobeNewswire
31/05
Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authoriza...
GlobeNewswire
30/05
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...
Newsfile Corp
30/05
Eywa, Dubai by R.Evolution, Wins the Title of World's Best Property, 2023-24, and Best International...
GlobeNewswire
22/05
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-...